학술논문

Association of HIV Suppression With Kidney Disease Progression Among HIV-Positive African Americans With Biopsy-Proven Classic FSGS
Document Type
article
Source
JAIDS Journal of Acquired Immune Deficiency Syndromes. 79(5)
Subject
Kidney Disease
Infectious Diseases
Rare Diseases
HIV/AIDS
Clinical Research
Evaluation of treatments and therapeutic interventions
6.1 Pharmaceuticals
Renal and urogenital
Infection
AIDS-Associated Nephropathy
African Americans
Biopsy
Disease Progression
Female
Glomerulosclerosis
Focal Segmental
HIV Infections
Humans
Male
Middle Aged
RNA
Viral
Retrospective Studies
Risk Assessment
Tertiary Care Centers
Viral Load
classic focal segmental glomerulosclerosis
HIV infected patients
chronic kidney disease
viral suppression
renal biopsy
Black or African American
Clinical Sciences
Public Health and Health Services
Virology
Language
Abstract
BackgroundIn the era of combined antiretroviral therapy, classic focal segmental glomerulosclerosis (FSGS) is the most common histopathological finding in African American HIV-positive patients with kidney disease. We sought to determine whether HIV suppression is associated with lower risk of progression to end-stage renal disease (ESRD) among HIV-positive African Americans with biopsy-confirmed classic FSGS.MethodsHIV-positive African Americans who underwent kidney biopsies at a single tertiary hospital between January 1996 and June 2011 were confirmed as having classic FSGS by the presence of segmental glomerulosclerosis without features of HIV-associated nephropathy. Multivariable Cox proportional hazards models were used to examine the independent association of viral suppression (HIV-RNA < 400 copies per milliliter at biopsy) with time to progression to ESRD.ResultsOf the 55 HIV-positive African Americans with classic FSGS, 26 had suppressed viral loads at the time of biopsy. Compared to viremic patients, those who were virally suppressed had a significantly higher mean CD4 cell count (452 vs. 260 cell/mm, respectively; P = 0.02) and median estimated glomerular filtration rate (53.5 vs 35.5 mL/min/1.73 m, respectively; P = 0.002). Adjusting for sex and baseline CD4 cell count, estimated glomerular filtration rate, and proteinuria, those with HIV-RNA levels